Company page
Moonlake Immunotherapeutics
Moonlake Immunotherapeutics is a public company listed under the ticker MLTX, operating in the American market. The company has a market capitalization of approximately $1.41 billion. Moonlake focuses on developing innovative immunotherapies to address unmet medical needs.
- Ticker
- MLTX:NASDAQ
- Asset type
- Stock
- Market cap
- $1.41B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD